Tirzepatide (Zepbound) came out on top against semaglutide (Wegovy) for treating obesity in the head-to-head SURMOUNT-5 trial.

Veru Inc (VERU) reports positive Phase 2B study ... significant reduction in the loss of lean mass in subjects receiving WEGOVY (p=0.002) -- -- Patients on Enobosarm on average lost 71% less ...

About Veru Inc. Veru is a late clinical stage biopharmaceutical ... patients receiving semaglutide (Wegovy®). The trial met its prespecified primary endpoint with a statistically significant ...

Veru is a late clinical-stage biopharmaceutical ... greater than or equal to 60 years of age receiving semaglutide, which is Wegovy, for weight for chronic weight management.

Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...

The treatment objective is for patients to have a healthier option for choosing to stop GLP-1s without the fear of fat regain,” said Mitchell Steiner, M.D., Chairman, President, and Chief Executive ...

The GLP-1 RA may be either WEGOVY (semaglutide ... to be Available for Phase 3 Clinical Studies and Commercialization Veru is currently developing a novel, patentable, modified release oral ...

Veru Inc. updates on its Phase 2b clinical trials ... patients receiving semaglutide (Wegovy Enobosarm + semaglutide treatment resulted in dose dependent greater loss of fat mass compared to ...

The GLP-1 RA may be either WEGOVY (semaglutide) and/or Zepbound® (tirzepatide ... is on Track to be Available for Phase 3 Clinical Studies and Commercialization Veru is currently developing a novel, ...

MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical ... significant reduction in the loss of lean mass in subjects receiving WEGOVY (p=0.002) -- - ...

-- Moderated discussion with preeminent obesity expert, Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder, of Veru -- MIAMI ...